Overview
Infantile impetiginized atopic dermatitis is a severe inflammatory skin condition in early infancy characterized by the overlap of atopic dermatitis and secondary impetiginization, often complicated by underlying immune deficiencies. 1Diagnosis
Clinical Presentation: Extensive dermatitis, often with signs of secondary infection (impetigo).
Laboratory Tests: Evaluation for complement deficiencies, particularly C5 component, and dysgammaglobulinemia.
Specific Tests: Complement C5 levels and immunoglobulin profile (IgG subclasses).
Differential Diagnosis: Consider Leiner's disease if immunodeficiency markers are present. 1Management
Antibiotics: Topical or systemic antibiotics targeting secondary bacterial infection (e.g., topical mupirocin, systemic flucloxacillin).
Emollients: Regular use of emollients to maintain skin barrier integrity.
Corticosteroids: Topical corticosteroids for inflammation control (potency varies based on severity).
Immunoglobulin Therapy: Consider in cases with confirmed hypogammaglobulinemia. 1Special Populations
Pediatrics: Early recognition and management crucial due to rapid progression and systemic involvement in infants. 1Key Recommendations
Evaluate for complement deficiencies (C5) and immunoglobulin levels in infants with severe, impetiginized atopic dermatitis to rule out underlying immunodeficiency. (Evidence: Moderate) 1
Initiate targeted antibiotic therapy for secondary bacterial infections, adjusting based on clinical response and microbiological findings. (Evidence: Moderate) 1
Regular follow-up and monitoring are essential in pediatric patients to manage complications and adjust treatment as necessary. (Evidence: Expert opinion) 1References
1 Evans DI, Holzel A, MacFarlane H. Yeast opsonization defect and immunoglobulin deficiency in severe infantile dermatitis (Leiner's disease). Archives of disease in childhood 1977. link